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Fourteen years after its initial description, the nuclear fac-
 
tor 
 
k
 
B (NF-
 
k
 
B) signaling pathway endures as a prime
example of rapidly responsive gene regulation (Sen and
Baltimore, 1986). Even with the complexities revealed
through the elucidation of converging activation pathways
and diverging downstream effectors, a generalized scheme
of NF-
 
k
 
B signaling remains elegant in its logic: (a) exter-
nal signals stimulate a kinase(s), such as NF-
 
k
 
B–inducing
kinase (NIK), MEKK1, Akt, or TBK1/NAK, which acti-
vates the inhibitor of NF-
 
k
 
B protein kinase (IKK); (b)
IKK then phosphorylates the inhibitor of NF-
 
k
 
B protein
(I
 
k
 
B) on two critical serine residues, which targets I
 
k
 
B for
ubiquitination and subsequent degradation by the 26S
proteasome; (c) previously held captive in the cytoplasm
through its association with I
 
k
 
B, the Rel/NF-
 
k
 
B dimeric
transcription factor is now free to enter the nucleus, find
its DNA sequence recognition motifs, and regulate tran-
scription (reviewed in Mercurio and Manning, 1999; Ozes
et al., 1999; Pomerantz and Baltimore, 1999; Romashkova
and Makarov, 1999; Tojima et al., 2000).
The ongoing examination of NF-
 
k
 
B signaling has re-
vealed its everexpanding role in stress responses, apopto-
sis, cell survival, oncogenesis, and development. The list of
potent inducers of NF-
 
k
 
B is also diverse and includes
proinflammatory stimuli such as tumor necrosis factor 
 
a
 
(TNF
 
a
 
), cytokines and interleukin 1
 
b
 
 (IL-1
 
b
 
), bacterial
and viral products, pro-apoptotic and necrotic stimuli
ranging from ultraviolet light and 
 
g
 
-irradiation to oxygen
free radicals, and, most recently, cell survival factors, e.g.,
neurotrophins (reviewed by Gerondakis et al., 1998; Foo
and Nolan, 1999; Li and Karin, 1999; Middleton et al.,
2000). While first discovered as a key regulatory factor of
the immune system, NF-
 
k
 
B is now recognized as an impor-
tant player in the functioning of many organs and cell
types. In the past few years, compelling evidence has been
accumulating to suggest that the diversity in the outcome
of NF-
 
k
 
B activation may be largely a reflection of the cell
type and differentiation state of the cell (Ozes et al., 1999;
Romashkova and Makarov, 1999; Ernfors, 2000).
In the skin, NF-
 
k
 
B plays a particularly central role in
epidermal biology. Perpetually subjected to the harmful
ultraviolet rays of the sun, the proliferative cells of the epi-
dermis may rely on NF-
 
k
 
B activation for protection and
survival (Fisher et al., 1996; Qin et al., 1999; Seitz et al.,
2000). More recent gain or loss of function studies in mice
suggest an equally important role in balancing growth and
differentiation in the epidermis. If correct, this would add
yet another provocative function for NF-
 
k
 
B in signaling
pathways.
 
Effectors: The Rel/NF-
 
k
 
B Family
 
The Rel/NF-
 
k
 
B transcription factor family includes five
members, c-Rel, RelA (p65), RelB, NF-
 
k
 
B1 (p50), and
NF-
 
k
 
B2 (p52), which function as hetero- or homodimeric
transcription factors (reviewed in Foo and Nolan, 1999).
Although other pairings exist, the most frequently encoun-
tered dimer consists of p50/p65. A 10-bp 
 
k
 
B consensus
binding site serves as the recognition site for most if not all
of the combinations of NF-
 
k
 
B family members, and genes
that carry this sequence can serve as downstream targets
for NF-
 
k
 
B activation. Given the known external stimuli
for NF-
 
k
 
B activation, it is not surprising that the list of tar-
get genes includes a number of NF-
 
k
 
B–regulated immune
genes, many of which encode acute-phase reactants to in-
flammation, oxidative or radiation stress, or tissue injury.
Mice have been generated that are null for each of the
Rel family members. Only the p65 null embryo, which dies
at embryonic day 16, displays an obvious defect external to
the immune system, namely apoptosis of hepatocytes (re-
viewed in Gerondakis et al., 1998; Beg et al., 1995b). How-
ever, double knockouts reveal more severe defects, such
as osteopetrosis and major abnormalities in B cell devel-
opment (p50/p52 double null) or enhanced inflammatory
defects (p50/RelB double null) (Franzoso et al., 1997;
Weih et al., 1997), suggesting the existence of some func-
tional redundancy within the Rel/NF-
 
k
 
B family.
No major skin defects have been noted in the single or
double null animals. However, since p65 single and double
null mice die by E16 at a time when epidermal stratifica-
tion and differentiation is still developing, skin-specific
knockouts will be needed to fully evaluate the effects of
this targeting event on epidermal differentiation (Beg et
al., 1995b; Grossmann et al., 1999; Horwitz et al., 1999).
Additionally, given its importance to this tissue, greater
redundancy might exist in the skin-specific expression of
Rel/NF-
 
k
 
B family members than in some other organs and
tissues. Thus, an understanding of the functional roles of
p65 and other Rel/NF-
 
k
 
B family members in epidermis
must await more rigorous examination of the skin of exist-
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ing Rel/NF-
 
k
 
B null animals coupled with future skin-spe-
cific targeting of the p65 gene and matings with viable Rel/
NF-
 
k
 
B null mice to eliminate possible redundancies.
 
Inhibitors: The I
 
k
 
B Family
 
As is the case for the Rel/NF-
 
k
 
B grouping, multiple I
 
k
 
B
family members exist, including I
 
k
 
B
 
a
 
, I
 
k
 
B
 
b
 
, I
 
k
 
B
 
g
 
, I
 
k
 
B
 
e
 
,
and BCL3. BCL3 is nuclear and seems to act by enhancing
NF-
 
k
 
B activation (Franzoso et al., 1992). With this excep-
tion, the other I
 
k
 
B proteins retain NF-
 
k
 
B dimeric com-
plexes in the cytoplasm and, thus, act as inhibitors. Of
these, I
 
k
 
B
 
a
 
 is perhaps the most well studied and function-
ally most relevant to this discussion (see mini-review, Bae-
uerle, 1998).
 
Receiving Release Papers and Gaining Freedom
 
Mice null for I
 
k
 
B
 
a
 
 are seemingly normal at birth, but they
eventually runt and develop dermatitis (Beg et al., 1995a;
Klement et al., 1996). Marked alterations in epidermal
morphology include excessive proliferation of basal kera-
tinocytes and a paucity of keratohyalin granules that typify
the granular layer, a late-stage feature of terminal differ-
entiation. Additionally, keratin 14, a marker of the prolif-
erative compartment of the epidermis, and keratin 16, typ-
ically induced in a variety of hyperproliferative skin
disorders, are expressed in the suprabasal compartment of
I
 
k
 
B
 
a
 
2
 
/
 
2
 
 epidermis, normally reserved for terminally dif-
ferentiating cells. While these phenotypic changes in skin
are dramatic, it is unclear whether they reflect direct con-
sequences of NF-
 
k
 
B elevation in the epidermis or result
secondarily from immune response dysfunction, another
prominent feature of the I
 
k
 
B
 
a
 
 null mouse (Beg et al.,
1995a). More recent studies suggest that the epidermal re-
sponse may indeed be secondary, at least in part, and
examination of I
 
k
 
B
 
a
 
 null skin grafted onto a mouse
wild-type for I
 
k
 
B/NF-
 
k
 
B function would be useful in dis-
tinguishing the features that arise due to an intrinsic defect
in I
 
k
 
B
 
a
 
 within the epidermis itself.
 
Getting a Grip on the Situation
 
NF-
 
k
 
B is differentially located in normal, unstressed epi-
dermis. As judged by immunofluorescence, p50 translo-
cates from the cytoplasm to the nucleus as epidermal cells
exit the basal layer and undergo terminal differentiation
(Seitz et al., 1998). Using an antibody to p65, the major
partner of p50, Takeda et al. (1999) find additional evi-
dence for nuclear NF-
 
k
 
B in a few basal cells, suggesting
that NF-
 
k
 
B activation may occur just before or concomi-
tant with exiting the cell cycle. To explore the possible
functional significance of NF-
 
k
 
B activation in the skin,
Seitz et al. (1998) have also sought to disrupt NF-
 
k
 
B sig-
naling in the basal layer of the epidermis. The researchers
used a keratin 14 promoter to target basal-specific expres-
sion of a constitutively stable form of I
 
k
 
B
 
a
 
 in which the
PEST sequence and IKK phosphorylation sites had been
mutated. At sufficiently high levels, this I
 
k
 
B
 
a
 
 inhibitor
was expected to prevent nuclear translocation (and there-
fore transactivation) of all known NF-
 
k
 
B family members.
Interestingly, mice expressing the K14-I
 
k
 
B
 
a
 
 mutant
 
transgene, I
 
k
 
B
 
a
 
M, exhibited skin and hair abnormalities
and by day 4 of postnatal development, runting was also
evident. Additionally, the epidermis was unusually thick,
displaying excessive suprabasal layers (Fig. 1 A, compare
with control in Fig. 1 B). This feature was a reflection of
hyperproliferation as judged by the persistence of DNA-
synthesizing cells in the suprabasal layers (Seitz et al.,
1998). Extending their analysis, these authors discovered
that pharmacological inhibition of NF-
 
k
 
B signaling could
also induce epidermal hyperplasia, suggesting that the ob-
served effects are directly attributable to suppression of
NF-
 
k
 
B activity at a time when basal cells would normally
activate this transcription factor and exit the cell cycle. In-
triguingly, if left unchecked, suppression of NF-
 
k
 
B in the
skin through stable I
 
k
 
B
 
a
 
 overexpression imparted an in-
vasive character to epidermal cells, leading to the appear-
ance of well-differentiated squamous cell carcinomas in
older transgenic animals or when transgenic epidermal
cells were transplanted onto the backs of immunocom-
promised mice (Seitz et al., 1998; van Hogerlinden et al.,
1999).
To further examine the possible link between NF-
 
k
 
B
signaling and cessation of epidermal proliferation, Seitz et
al. (1998) also generated mice expressing a transactivating
p50 or p65 under the control of the keratin 14 promoter. In
this case, nuclear, i.e., activated, NF-
 
k
 
B was seen through-
out the skin, and as predicted from the converse experi-
ment, a thin, hypoproliferative epidermis was the outcome
(Fig. 1 C, example shown is p50 overexpression). The ab-
normalities in epidermis that occurred as a consequence of
alterations in NF-
 
k
 
B signaling appeared to be restricted to
defects in proliferative state: neither activating nor re-
pressing NF-
 
k
 
B signaling altered the suprabasal expres-
sion patterns of the differentiation-specific markers, kera-
tin 10, involucrin, transglutaminase 1, or filaggrin.
From these data, we can begin to speculate about the
role of NF-
 
k
 
B signaling in the epidermis. An attractive
possibility is that NF-
 
k
 
B activation is necessary to either
cause or maintain cell cycle arrest as keratinocytes commit
to terminally differentiate and exit the basal layer. In this
regard, the behavior of the epidermis seems to be opposite
from that of the immune system, where NF-
 
k
 
B activity
seems to play a positive role in proliferation (reviewed in
Gerondakis et al., 1998). NF-
 
k
 
B has been associated with
promotion of apoptosis in double positive thymocytes (Hett-
mann et al., 1999), and although controversial, NF-
 
k
 
B acti-
vation may promote cell death in some neurons exposed
to ischemia, oxidative stress, or excitotoxicity (Ernfors,
2000). Thus, while an apparently antiproliferative effect of
NF-
 
k
 
B is less common, it is not without some precedent.
A number of issues remain unsettled. In two separate
studies using similar I
 
k
 
B-stabilizing mutants driven by
basal epidermal keratin promoters, the mice either died
after 4–7 d (Seitz et al., 1998) or survived for at least 4 mo
(van Hogerlinden et al., 1999), leaving open the possibility
that, at least in certain cases, transgenic manipulation of
NF-
 
k
 
B signaling using protein overexpression can lead to
consequences that are not necessarily physiologically rele-
vant. In addition, by using a basal keratin promoter to ex-
press a highly stable I
 
k
 
B mutant, it is likely that the inhibi-
tor persisted in the suprabasal layers of epidermis. Hence,
it remains unclear as to whether the alterations induced by 
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perturbations in NF-
 
k
 
B signaling arise from transcriptional
changes in basal or alternatively in suprabasal cells. This lat-
ter issue is especially important in distinguishing whether
NF-
 
k
 
B activation might be a critical event in initiating
withdrawal from the cell cycle as cells leave the basal layer
or, rather, if this signal is crucial in maintaining the post-
mitotic state of suprabasal cells. In the future, suprabasal-
specific expression of the I
 
k
 
B mutant under the control of
the differentiation-specific involucrin promoter will help to
distinguish between these possibilities. A final curiosity is
that both groups noted perturbations in hair development.
The mechanism by which hair development and/or differ-
entiation might be dependent upon the NF-
 
k
 
B signaling
machinery is an area that also merits further investigation.
 
Regulators: The IKK Complex
 
An important feature of NF-
 
k
 
B regulation is the phosphor-
ylation of the I
 
k
 
B inhibitor and its subsequent targeting
for ubiquitin-mediated degradation. In the last several
years, the elusive I
 
k
 
B regulatory kinase was identified
and shown to consist of two catalytic subunits, IKK1 and
IKK2 (DiDonato et al., 1997; Mercurio et al., 1997; Reg-
nier et al., 1997), and a regulatory subunit, referred to al-
ternatively as IKK
 
g, IKKAP-1, FIP-3, or NEMO (Roth-
warf et al., 1998; reviewed in Mercurio and Manning,
1999). The story appears even more complex as a recently
identified kinase, termed IKK-i or IKKe, may function in a
different IkB regulatory complex (Shimada et al., 2000;
Peters et al., 2000). In the past year, the consequences of
ablating the IKK1, IKK2, and NEMO/IKK-g subunits
were explored using gene knockout technology in mice (Li
et al., 1999a; Takeda et al., 1999; Hu et al., 1999; Rudolph
et al., 2000).
In the absence of IKK1, embryos died at birth, exhibit-
ing gross abnormalities typified by a shiny epidermis, a
shortened tail, and seemingly stunted limb growth. The
shiny appearance of the epidermis was a consequence of
an impairment in the epidermal barrier. This was accom-
panied by a hyperthickened spinous layer and a paucity of
typical keratinized, enucleated squames (Fig. 1, D–E). In
addition, expression of late-stage terminal differentiation
markers, e.g., loricrin and filaggrin, was noticeably re-
duced.
In agreement with both IKK’s role as an instigator of
IkB degradation and the induction of nuclear NF-kB as
normal basal cells commit to terminally differentiate, basal
cells of IKK1 null epidermis displayed an increase in IkBa
and IkBb immunostaining, and a cytoplasmic restriction of
NF-kB. The thickened epidermis was consistent with a
Figure 1. An unusual corre-
lation between NF-kB activa-
tion and cell cycle arrest in
the epidermis. (A–C). Histol-
ogy of skin from transgenic
mice overexpressing stabi-
lized IkBa (A) or the p50
subunit of NF-kB (C) under
the control of the basal epi-
dermal specific human K14
promoter. Shown is a skin
section from a nontransgenic
littermate (LM) for compari-
son (B). Brackets show thick-
ness of epidermis. (Figure
courtesy of P. Khavari; re-
printed with permission from
Seitz, C.S., Q. Lin, H. Deng,
and P.A. Khavari. 1998. Al-
terations in NF-kB function
in transgenic epithelial tissue
demonstrate a growth inhibi-
tory role for NF-kB.  Proc.
Natl. Acad. Sci. USA. 95:
2307–2312. Copyright 1998.
National Academy of Sci-
ences, USA.) (D–E). Dorsal
skin from wild-type (D) and
IKK12/2 (E) embryos
(E185). (Figure courtesy of S.
Akira; reprinted with permis-
sion from Takeda, K., O.
Takeuchi, T. Tsujimura, S.
Itami, O. Adachi, T. Kawai,
H. Sanjo, K. Yoshikawa, N. Terada, and S. Akira. 1999. Limb and skin abnormalities in mice lacking IKKa. Science. 284:313–316. Copy-
right 1999. American Association for the Advancement of Science.) SC, stratum corneum; GR, granular layer; SP, spinous layer; BL,
basal layer. Bars: (A–C) 75 mm; (D–E) 30 mm.The Journal of Cell Biology, Volume 149, 2000 1002
model whereby failure to activate epidermal NF-kB re-
sults in hyperproliferation due to a failure of transiently
amplifying basal cells to withdraw from the cell cycle.
However, alterations in terminal differentiation had not
been previously seen when IkB levels were elevated in the
basal layer of transgenic epidermis (Seitz et al., 1998).
These findings suggested that the effects of IKK ablation
in the skin may go beyond mere elevation of IkB in the
basal layer.
Another mystery still unsolved is how IKK1 ablation
might restrict appendage outgrowth in developing mouse
embryos. A clue stems from the fact that the limb and tail
bones were only slightly retarded, suggesting that the limb
defects could be a secondary event caused by IKK1-medi-
ated defects in the skin. One possibility is that signaling
between developing ectoderm and mesoderm in the limbs
is dependent, to some degree, on IKK1 activity and, most
likely, NF-kB activity. Indeed, limb outgrowth is known to
involve lateral migration of keratinocytes as well as mes-
enchymal-epithelial interactions, and in this regard, it is
likely relevant that the skin of the IKK1 null animals was
taut, lacking folds or wrinkles. Additionally, haptotactic
migration of keratinocytes in cell culture seems to be de-
pendent upon functional NF-kB signaling (Benoliel et al.,
1997), further pointing to the notion that defects in epider-
mal migration may underlie the limb abnormalities in the
IKK1 null embryos. NF-kB activity. While additional stud-
ies will be necessary to assess the extent to which this hy-
pothesis may be correct, a defect in cell migration could in-
directly influence epidermal thickness and proliferation.
Another factor likely to be relevant is that NF-kB acti-
vation plays a central role in cell survival through its abil-
ity to block or reduce apoptosis in various cell types in-
cluding keratinocytes (Chaturvedi et al., 1999; Seitz et al.,
2000). It is possible, therefore, that elimination of NF-kB
activation may result in ablation of cells or altered signal-
ing in the progress zone of the limb bud (Bushdid et al.,
1998; Kanegae et al., 1998), thereby accounting at least in
part for the defects observed.
This issue prompts us to revisit the question of why the
phenotype of the IKK1 null mouse is markedly more se-
vere than that of various transgenic mice expressing con-
stitutively stabilized IkB in the basal epidermal layer.
Since basal layer NF-kB appeared to be restricted to the
cytoplasm in both types of mice, it seems unlikely that the
differences are rooted in variations in overall levels of
basal epidermal IkB.  A priori, it could be that the in-
creased severity in IKK12/2 mice is due to stabilization
of IkB within all skin cells, rather than only basal epider-
mal cells. While this possibility seems likely, a more in-
Figure 2. NF-kB signaling in
the epidermis: balancing cell
cycle withdrawal, cell sur-
vival, and differentiation.
Model is based upon a classi-
cal role for NF-kB in cell sur-
vival but an atypical role for
NF-kB in promoting cell cy-
cle withdrawal in the epider-
mis. NF-kB appears to be ac-
tivated concomitant with the
time at which basal epider-
mal cells withdraw from the
cell cycle and commit to ter-
minally differentiate. Termi-
nal differentiation in the epi-
dermis requires a series of
transcriptional changes in the
absence of proliferation to
enable the epidermal barrier
to be established. This bar-
rier is essential to keep bodily
fluids in and harmful micro-
organisms out. Terminally
differentiated squames are
then shed from the skin sur-
face, continually being re-
placed by basal cells with-
drawing from the cell cycle,
committing to differentiate,
and transiting outward. The
convergence of cell survival
and cell cycle arrest path-
ways, linked through NF-kB,
may help to balance homeo-
stasis in the epidermis and
coordinate these processes.Kaufman and Fuchs It’s Got You Covered: NF-kB in the Epidermis 1003
triguing notion is that as yet unidentified substrates for
IKK1 exist that might influence pathways extending be-
yond NF-kB signaling. In this regard, it may be relevant
that IkB and b-catenin, another key protein in the skin,
contain similar sequences that are phosphorylated as an
important step in regulating their stability (Aberle et al.,
1997). Interestingly, recent evidence has shown that a
specificity factor in the ubiquitination pathway, referred to
as Slimb in flies and b-TRcP in mammals, is involved in
recognizing this phosphorylated sequence in both IkB and
b-catenin (reviewed in Maniatis, 1999). It is tempting to
speculate that a kinase, such as IKK1, may also recognize
this sequence in both proteins, although other protein do-
mains may also contribute to kinase specificity. As b-cate-
nin stabilization has been implicated in epidermal stem
cell character and/or maintenance (Gat et al., 1998; Zhu
and Watt, 1999), and Wnt/Wingless signaling is likely to be
involved in epidermal and/or hair follicle development/dif-
ferentiation, the more severe phenotype of the IKK12/2
mice could reflect a more complex role for IKK1 in
governing processes beyond the NF-kB pathway where
protein stability is involved in transcriptional regulation.
Strengthening the Foundation and
Looking Ahead
With the potential of IKK1 to affect multiple signal trans-
duction pathways, additional studies will be necessary to
fully understand the IKK1 null phenotype at a molecular
level. This said, based upon the prior transgenic mouse
studies with stabilized forms of IkB, epidermal hyperpro-
liferation was both an expected and observed feature of
IKK1 null animals. Additionally, it is notable that in the
IKK1 null embryos, IL-1– and TNFa-induced activation of
NF-kB was not impaired, while these responses were di-
minished in IKK2 and NEMO/IKKg null embryos (Li et
al., 1999b; Rudolph et al., 2000). Thus, it appears that com-
ponents of IKK may have distinct roles in controlling NF-
kB activation, and our understanding of the response to
proinflammatory stimuli is likely not sufficient to explain
in full how NF-kB might impact on balancing growth and
differentiation in the epidermis.
Present literature would seem to suggest that NF-kB
plays a role in either inducing an epidermal cell to with-
draw from the cell cycle and/or in maintaining this state
once achieved. If future studies substantiate this notion,
then NF-kB would have a different role in the epidermis
than it has in other cell types such as lymphocytes and neu-
rons. NF-kB family members were first identified as the
cellular equivalents of viral oncogenes and also as translo-
cated genes in T and B cell cancers (for review, see Foo
and Nolan, 1999). While these observations contribute to
the view that NF-kB acts to enhance proliferation, many
of NF-kB’s stimulatory effects have been attributed to its
powerful ability to protect against apoptosis. Thus, in most
situations, activation of NF-kB does not actually promote
cell cycle progression.
Recent evidence indicates that, as in most other cell
types, epidermal NF-kB protects against apoptosis, appar-
ently by enhancing the expression of anti-apoptotic factors
(Seitz et al., 2000). At first glance, this finding might only
serve to reinforce the apparent paradox as to why antago-
nizing NF-kB, as with IkB stabilization and/or IKKa abla-
tion, would lead to an increase in cellularity within epider-
mis, whereas in most tissues a decrease in cellularity would
be expected. However, this new finding illuminates a pos-
sible role for NF-kB in epidermis that is uniquely tailored
to suit the specialized properties of this tissue. Indeed, the
unusual correlation between cell cycle withdrawal and ac-
tivation of epidermal NF-kB is intriguing in this regard,
since cell cycle arrest is emerging as a prerequisite for pro-
tection from apoptosis (Foo and Nolan, 1999). Given that
NF-kB seems to be prominent in the earlier stages of ter-
minal differentiation, it could be that through protection
from apoptosis, spinous cells are able to execute and com-
plete their differentiation-specific program of transcrip-
tional changes necessary to produce the epidermal barrier
and protect our terrestrial bodies from dehydration and
microbial invasion (Seitz et al., 2000). By linking cell cycle
withdrawal and protection from apoptosis, NF-kB is able
to coordinate and monitor both homeostasis within the
epidermis, as well as the successful transition of the epi-
dermal cell from the basal to suprabasal layers.
A model summarizing the putative functions of NF-kB
in the epidermis is presented in Fig. 2. The extent to which
this view is correct must now await the identification of
NF-kB target genes in the epidermis and an understanding
of how these transcripts differ in response to different
means of NF-kB activation. As the list of NF-kB target
genes in the epidermal keratinocyte and other cell types
becomes comprehensive, comparisons between cell types
and differentiation states should help us to understand the
underlying bases for the various responses. A more thor-
ough characterization of the particular NF-kB family
members expressed in the epidermis will also be needed,
and in this regard, removal of redundancies might be
needed in order to further dissect the role of NF-kB from
the myriad of other changes associated with the early
stages of terminal differentiation. Given the vibrance and
fast pace of the field of NF-kB signaling, a coherent under-
standing of the present mysteries and complexities of NF-
kB and its many intersecting signaling crossroads will
likely evolve and further contribute to our understanding
of cell growth, differentiation, and death in the epidermis.
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